Abstract:Prions are proteins that can adopt at least 2 distinct conformations (structural states), being one of them soluble, either natively folded or intrinsically disordered, and the other an aggregated fibrillar structure, termed amyloid, made of stacked ß-strands contributed by the individual protein molecules [1]. Amyloids propagate their conformation to soluble protein molecules of their same kind by contact, capturing them as new building blocks of their elongating fibers. Conformational variants (i.e., alternative 3D folds for the same protein sequence) of an amyloid assembly can be propagated as distinct prion strains vertically with cell division, from mother to daughter cells, for many generations constituting a case for cytoplasmatic, non-mendelian epigenetic inheritance [1]. After the pioneering discovery of the mammalian prion protein PrP [2], the whole field was boosted by findings in the yeast Saccharomyces cerevisiae , in which several transcriptional and translational factors (such as Sup35 and Ure2) were shown to aggregate as amyloids, resulting in loss-of-function phenotypes ([ PSI + ] and [ URE3 ], respectively) [3,4]. Alternative strains of yeast prions were horizontally transmissible between cells while mating through cytoduction (i.e., cytoplasmatic mixing) [5]. In yeast, depending on the protein, its amyloid state either elicits a functionally adaptive phenotypic change or becomes cytotoxic and deleterious [6,7]. Horizontal transmission as an infectious agent has been recently described also for amyloid proteins involved in human neurodegenerative diseases such α-synuclein, Tau, the ß-amyloid peptides, and TDP-43, self-propagating as prion-like proteins (or prionoids) between cells within different areas of the central nervous system [8]. In bacteria, as exemplified by the Escherichia coli biofilm scaffolding protein CsgA, some extracellular secreted proteins rely on a complex, dedicated protein machinery for their regulated assembly as functional amyloids, with defined fibrillar structures and physiological roles [9]. These are distinct to prions, in which the soluble monomers are functional while the amyloid fibrils that they assemble, usually polymorphic, lose that function [8]. Mining in prokaryotic proteomes identified many proteins with potential prion forming domains (PrDs), typically intrinsically disordered (IDPs) and with overall polar residue composition, similar to those in yeast prions [10,11]. However, so far detailed experimental characterization of bacterial prions is restricted to individual domains in just 3 proteins adopting an amyloid state (Fig 1).

Electron Microscopy Study of the Structure of the Sup35 Prion from Yeast Saccharomyces cerevisiae

Mechanism and Application of Molecular Self-Assembly in Sup35 Prion Domain of Saccharomyces Cerevisiae

Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

Polymorphism Of Amyloid Fibrils Formed By A Peptide From The Yeast Prion Protein Sup35: Afm And Tip-Enhanced Raman Scattering Studies

The Effect of Mechanical Shocks on the Initial Aggregation Behavior of Yeast Prion Protein Sup35NM.

Molecular chaperones and the assembly of the prion Sup35p, an in vitro study

Oligomerization of Yeast Prion Sup35NM

Insight into Sup35(7-13) Misfolding and Interactions Using Molecular Dynamics Simulation

Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35

Cryo-EM Structure of an Amyloid Fibril Formed by Full-Length Human Prion Protein

In Situ Molecular-Level Insights into the Interfacial Structure Changes of Membrane-Associated Prion Protein Fragment [118-135] Investigated by Sum Frequency Generation Vibrational Spectroscopy.

Amyloid Nucleation and Hierarchical Assembly of Ure2p Fibrils: ROLE OF ASPARAGINE/GLUTAMINE REPEAT AND NONREPEAT REGIONS OF THE PRION DOMAIN

Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and Its Derivatives

The emergence of bacterial prions

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Osmotic stress induces formation of both liquid condensates and amyloids by a yeast prion domain

The Physical Dimensions Of Amyloid Aggregates Control Their Infective Potential As Prion Particles

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Substoichiometric Hsp104 regulates the genesis and persistence of self-replicable amyloid seeds of Sup35 prion domain

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

Electrostatics in the Stability and Misfolding of the Prion Protein: Salt Bridges, Self-Energy, and Solvation